882-P: Eloralintide, a Selective, Long-Acting Amylin Receptor Agonist for Obesity—Phase 1 Proof of Concept
用户ZaC9B12dnZDM
3个月前
468
10
已关闭
DOI: 10.2337/db25-882-p
其他信息:
出版社: American Diabetes Association
作者: SHOBHA N. BHATTACHAR; LAI-SAN THAM; BETH TIDEMANN-MILLER; DANIEL A. BRIERE; HONGCHANG QU; AXEL HAUPT; EDWARD J. PRATT; KIEREN J. MATHER
全文下载地址: https://diabetesjournals.org/diabetes/article/74/Supplement_1/882-P/159628/882-P-Eloralintide-a-Selective-Long-Acting-Amylin